SEARCH
Current Location:
>
> This Story


Log in or Register to rate this News Story
Forward Printable StoryPrint Comment

Never Miss a Story

Sign up for email alerts

 

More Industry Headlines

King v. Burwell: Interpreting five words in the ACA The Supreme Court case that could topple Obamacare

European Congress of Radiology meeting 2015: Talking with Nikola Tesla honorary lecturer Dr. Anne Osborn Dr. Anne Osborn, the Nikola Tesla honorary lecturer at the European Society of Radiology Annual Congress, spoke with DOTmed about the latest in radiogenomics

2015 European Congress of Radiology Annual Conference update: March 5 Today’s Honorary Lecture: Dr. John A. Brink, Radiologist-in-Chief at Massachusetts General Hospital and Juan M. Taveras, Professor of Radiology at Harvard Medical School

First CyberKnife treatment using InCise MLC complete InCise multileaf collimator cuts treatment time in half

2015 European Congress of Radiology Annual Conference update: March 4 The 2015 European Congress of Radiology Annual Conference began March 4, with more than 20,000 attending.

Different initiatives, common goals: Varian and GE set sights on Africa's cancer problem Less than half of the countries in Africa offer access to radiotherapy

The rising rate of hospital shootings: What health care professionals need to know How can a hospital protect itself from shootings, and what should be done if a shooting occurs?

Cardiology: how smaller hospitals can provide top-level care Smaller hospitals have found new ways to provide quality care to patients

Is the Mo-99 shortage over? Nordion, MURR, General Atomics form production partnership The Sterigenics International subsidiary will focus on LEU Mo-99 production process

Olympus facing suits for infection and death of patients at UCLA Olympus Corp. of the Americas is facing suits for infections allegedly stemming from use of its duodenoscopes

ProCure's N.J. center (Credit: ProCure)

N.J. proton therapy center opens today

by Brendon Nafziger , DOTmed News Associate Editor
A New Jersey proton therapy center opening today is the first to operate in the greater New York region and only the tenth such center nationwide.

ProCure Treatment Centers Inc, a developer of for-profit centers that offer the high-tech cancer treatment, said it was hosting a ribbon-cutting ceremony this morning for the $160 million facility. The 60,000-square foot center, ProCure's third, is located in Somerset, about a half-hour drive away from New York City.

Story Continues Below Advertisement

Click here to learn more about McKesson's Enterprise Imaging solutions

Today, essential tools like Enterprise Image Repository, ClinicalData Exchange, quality workflow solutions and more are helping connect medical professionals across entire enterprises like never before. Find out more>>>



The ProCure Proton Therapy Center features four treatment rooms: two inclined beam rooms, a gantry room, and a fixed beam room. One inclined beam room is opening now, but the company told DOTmed News by email it hopes to get the rest of the rooms online within a year.

As with ProCure's other two centers in Oklahoma City and Warrenville, Ill., it houses a massive, particle-firing cyclotron made by Belgian manufacturer IBA.

The center took under two years to build, the company said.

Princeton Radiation Oncology, a 10-doctor radiation therapy group in New Jersey and Pennsylvania, will provide clinical care at the new facility, and CentraState Health System, a nonprofit regional health group, will offer access to medical services not provided by the center but which patients might need while undergoing proton therapy, ProCure said.

ProCure said it has been evaluating patients since February, and the first patient will be treated March 26.

"It has been a long-time dream of mine to bring proton therapy closer to home," Dr. Brian Chon, medical director of the center and a radiation oncologist with Princeton Radiation Oncology, said in a statement.

Proton therapy works by accelerating protons to two-thirds the speed of light and shooting them at cancer cells to scramble their DNA. Because of the nature of protons, the radiation dose falls rapidly away from the target, theoretically letting doctors minimize the dose to healthy tissue. While many doctors think this could be especially beneficial for children with tricky spine and brain cancers, the technology has been the subject of some controversy, largely owing to the high costs of developing treatment centers.

ProCure, headquartered in New York City, has a center in Seattle set to open next year, as well as others in development in Michigan and Florida.

The company cited estimates that more than 150,000 New Yorkers and New Jerseyans will be diagnosed with cancer each year.

Related:


Interested in Medical Industry News? Subscribe to DOTmed's weekly news email and always be informed. Click here, it takes just 30 seconds.

You Must Be Logged In To Post A Comment

Advertise
Increase Your
Brand Awareness
Auctions + Private Sales
Get The
Best Price
Buy Equipment/Parts
Find The
Lowest Price
Daily News
Read The
Latest News
Directory
Browse All
DOTmed Users
Ethics on DOTmed
View Our
Ethics Program
Gold Parts Vendor Program
Receive PH
Requests
Gold Service Dealer Program
Receive RFP/PS
Requests
Healthcare Providers
See all
HCP Tools
Jobs/Training
Find/Fill
A Job
Parts Hunter +EasyPay
Get Parts
Quotes
Recently Certified
View Recently
Certified Users
Recently Rated
View Recently
Certified Users
Rental Center
Rent Equipment
For Less
Sell Equipment/Parts
Get The
Most Money
Service Technicians Forum
Find Help
And Advice
Simple RFP
Get Equipment
Quotes
Virtual Trade Show
Find Service
For Equipment
Access and use of this site is subject to the terms and conditions of our LEGAL NOTICE & PRIVACY NOTICE
Property of and Proprietary to DOTmed.com, Inc. Copyright ©2001-2015 DOTmed.com, Inc.
ALL RIGHTS RESERVED